Glicazide

Chemical

Sulphonylurea

Use

  1. T2DM

Presentation

Tablets

Dose

40-160mg daily

Route

PO

Onset

2-8hrs

DoA

10-24h

MoA

Bind sulphonylurea receptor of b-cells in pancreas

Close KATP channels

Depolarises b -cell

Ca++ influx

Exocytosis of insulin containing vesicles

Increase peripheral [insulin]

 Pre-requisite of adequate b-cells function

PD

Improves insulin dynamics

PK

A

Rapid & good absorption

D

PPB 94%

M

Extensively in liver.  Oxidised & hydroxylated derivatives, glucuronic acid conjugates

E

Metabolites in urine & faeces

Adverse Effects

Hypoglycaemia in starved state – must be stopped preop

Weight gain

GI disturbances

Contraindicated

Elderly

Renal impairment

Fasting